Something I’ve been thinking about — · Peptides: Out of the Shadows

Something I’ve been thinking about —

A lot of the simpler / naturally occurring peptides never seem to get real investment or approval.

One angle is this:

If something already exists in the body, it generally can’t be patented in its natural form. That changes the incentive completely.

So you end up with:• less ownership potential• less large-scale investment• less push toward approval

Curious how others see this —

Do you think lack of patents is a big reason certain compounds stay in the “underground” space?

Or is it something else entirely?

0 comments

skool.com/monument-method-2583

Your Body. Your Code.

The science is out. The code is yours to write.

A place to share real peptide experiences and see what’s actually working.

Bring people together around your passion and get paid.